Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-13 Purchase | 2023-11-15 4:48 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 849,854 | $5.87 | $4,988,643 | 5,329,346 (Indirect) | View |
| 2023-11-13 Purchase | 2023-11-15 4:46 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect) | View |
| 2023-11-13 Purchase | 2023-11-13 7:11 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect Direct) | View |
| 2023-07-19 Purchase | 2023-07-21 4:31 pm | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-29 Other | 2024-03-04 7:31 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 1,016,200 | $0 | 5,009,239 (Direct) | View |
| 2024-02-29 Other | 2024-03-04 4:44 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 2,986 | $0 | 111,014 (Direct) | View |
| 2024-02-29 Other | 2024-03-04 4:33 pm | N/A N/A | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 1,493 | $0 | 67,036 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:54 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 111,000 | $0 | 111,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:53 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer | 151,500 | $0 | 151,500 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:52 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 157,000 | $0 | 157,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:50 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:49 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 356,500 | $0 | 356,500 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:47 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 147,000 | $0 | 147,000 (Direct) | View |
Ownership | 2024-01-03 4:45 pm | N/A N/A | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 0 | $0 | 746,332 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:15 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 12,500 | $0 | 12,500 (Indirect) | View |
| 2023-06-14 Option Award | 2023-06-16 5:10 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:09 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | McNulty Alana B. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:08 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Simson Jake Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:08 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Kung Winston Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:07 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:06 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:06 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Barrett Ronald W Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:36 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:35 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:34 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:33 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:32 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Godfrey Wayne Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:30 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer | 310,000 | $0 | 310,000 (Direct) | View |
Ownership | 2023-01-05 4:29 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 0 | $0 | 217,629 (Direct) | View |
| 2022-09-21 Option Award | 2022-09-22 6:00 pm | N/A 2032-09-20 | Janux Therapeutics Inc. | JANX | Kung Winston Director | 39,375 | $0 | 39,375 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:39 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Barrett Ronald W Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:37 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:36 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | McNulty Alana B. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:35 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:33 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Heller Stefan Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:32 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:31 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 12,500 | $0 | 12,500 (Indirect) | View |